Skip to content

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06381284
Enrollment
215
Registered
2024-04-24
Start date
2024-03-28
Completion date
2025-03-03
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

Keywords

Social Media, Myasthenia Gravis

Brief summary

This is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The main study objective is to evaluate the feasibility of a social media recruitment campaign tied to a participant reported symptom survey and self-administered physical assessment tool to influence undiagnosed participants to seek care for suspected Myasthenia Gravis (MG).

Detailed description

Participants with undiagnosed neuromuscular symptoms will be targeted via social media paid advertisements to recruit them to our study landing page (weblink: https://bit.ly/unearthrootcause). Two assessment tools were developed by the study team: the Impact of Daily Living (IDL) Survey and the MG Exercise Assessment. Both tools were designed using supporting literature, accepted guidelines, and a rigorous review via a panel of practicing neurologist key opinion leaders experienced in treating MG patients. Adult participants who don't have specific diagnosed neurologic conditions will first be screened for eligibility based on the results of the IDL survey which will query participants on the presence or absence of habits/symptoms characteristic of MG. Those who qualify will complete the MG Exercise Assessment in which participants are provided video instructions to perform a series of 10 physical tests to examine if specific muscle groups undergo inducible fatigue. The results of the MG Exercise Assessment are reviewed by a neurologist to determine if participants would benefit further from an in-person neurologist evaluation for MG by a provider. Each participant is provided with a report of the neurologist's evaluation. Participants will be followed for 1 year through bimonthly communications to determine if and when they followed up with a clinician and if they received a confirmed diagnosis of myasthenia gravis.

Interventions

Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment

BEHAVIORALSelf-Assessment

Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups

BEHAVIORALFollow-up

Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis

Sponsors

UCB Pharma
CollaboratorINDUSTRY
University of California, San Francisco
CollaboratorOTHER
ZS Associates
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Reside within the 50 states of the United States at the time of enrollment * Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state * Active email account * Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form

Exclusion criteria

* Live in an overseas territory of the United States * Inability or unwillingness to provide written informed consent * Diagnosed myasthenia gravis * Diagnosed multiple sclerosis * Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke

Design outcomes

Primary

MeasureTime frameDescription
Social media recruitment feasibilityEnrollment period (4-6weeks)Measure the engagement and feasibility metrics of the social media campaign

Secondary

MeasureTime frameDescription
MG Exercise Assessment Tool validity1 year from time of enrollmentEstimate preliminary measures of validity for the MG Exercise Assessment Tool

Other

MeasureTime frameDescription
Time to diagnosis1 year from time of enrollmentEvaluate the time to diagnosis for any participant who has a confirmed diagnosis of MG after the completion of the study compared to that reported in literature

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026